摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Azido-3,3-dimethylbutan | 13686-08-3

中文名称
——
中文别名
——
英文名称
1-Azido-3,3-dimethylbutan
英文别名
3.3-Dimethyl-butylazid;1-azido-3,3-dimethyl-butane;1-Azido-3,3-dimethylbutane
1-Azido-3,3-dimethylbutan化学式
CAS
13686-08-3
化学式
C6H13N3
mdl
——
分子量
127.189
InChiKey
JSXWSVUHDJNFKB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    42-43 °C(Press: 15 Torr)
  • 密度:
    0.7685 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    14.4
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • STIMULI-SWITCHABLE MOIETIES, MONOMERS AND POLYMERS INCORPORATING STIMULI-SWITCHABLE MOIETIES, AND METHODS OF MAKING AND USING SAME
    申请人:THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    公开号:US20170267689A1
    公开(公告)日:2017-09-21
    Stimuli-switchable moieties, monomers incorporating stimuli-switchable moieties, and polymers incorporating such stimuli-switchable moieties are provided. The stimuli-switchable moiety can be a pyrano aryl chromenone-derivative. The stimuli-switchable monomer can be a lactone monomer. The stimuli-switchable monomer can be an amino acid, which can be incorporated into a specific peptide sequence by peptide synthesis.
    提供刺激响应性基团、包含刺激响应性基团的单体以及包含此类刺激响应性基团的聚合物。刺激响应性基团可以是喃并芳基色烯酮衍生物。刺激响应性单体可以是内酯单体。刺激响应性单体可以是氨基酸,其可以通过肽合成并入特定的肽序列中。
  • Pritzkow,W.; Timm,D., Journal fur praktische Chemie (Leipzig 1954), 1966, vol. 32, p. 178 - 189
    作者:Pritzkow,W.、Timm,D.
    DOI:——
    日期:——
  • QUAST, H.;BERNETH, C. -P., CHEM. BER., 1983, 116, N 4, 1345-1363
    作者:QUAST, H.、BERNETH, C. -P.
    DOI:——
    日期:——
  • HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
    申请人:INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY
    公开号:US20170015658A1
    公开(公告)日:2017-01-19
    The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
  • BETA-1,6-GLUCAN CETUXIMAB ANTIBODY CONJUGATES
    申请人:ImmuneXcite, Inc.
    公开号:US20180154014A1
    公开(公告)日:2018-06-07
    The present invention encompasses embodiments in which cetuximab or a related cetuximab antibody is conjugated to β-1,6-glucan oligomers. Thus, the present invention includes, among other things, compositions including cetuximab conjugated to one or more β-1,6-glucan oligomers. The present invention further includes, among other things, methods of making and/or using such β-1,6-glucan conjugates. In certain embodiments, a β-1,6-glucan conjugate of the present invention is useful as a therapeutic or in a method of therapy.
查看更多